Parkinson's Disease Support Protocol
Parkinson's Disease Support Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A neuroprotective and dopaminergic support protocol for individuals with Parkinson's disease or early Parkinsonism. Targets the progressive loss of substantia nigra dopaminergic neurons by combining neurotrophic support, mitochondrial protection, neuroinflammation reduction, and alpha-synuclein aggregation inhibition.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Parkinson's Disease Support Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing maintenance protocol with quarterly Epithalon pulses; Cerebrolysin in 4-week intensive cycles quarterly
Target Audience
Adults with early to moderate Parkinson's disease or Parkinsonism under neurologist supervision
| Compound | Dose | Frequency |
|---|---|---|
| Cerebrolysin Neurotrophic support for surviving dopaminergic neurons; BDNF/GDNF analog activity | 5–10 mL | Daily for 4 weeks, then 3x/week |
| Semax BDNF upregulation and dopaminergic neurotoxicity reduction via ACTH-analog neuroprotection | 600 mcg | Twice daily |
| BPC-157 Dopaminergic signaling restoration and neuroinflammation reduction | 500 mcg | Twice daily |
| Humanin Inhibits mitochondrial apoptosis in dopaminergic neurons; reduces alpha-synuclein toxicity | 2 mg | Daily |
| NAD+ Restores mitochondrial Complex I function — primary metabolic defect in PD | 1000 mg | Daily |
| Epithalon Pineal-hypothalamic neuroprotection and circadian normalization; quarterly 10-day pulses | 10 mg | Daily x10 days per quarter |
Free Peptide Guide
Parkinson's Disease Support Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Cerebrolysin timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Parkinson's Disease Support Protocol run before reassessment?
A common window is Ongoing maintenance protocol with quarterly Epithalon pulses; Cerebrolysin in 4-week intensive cycles quarterly, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Cerebrolysin + Semax execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Parkinson's disease is characterized by progressive dopaminergic neuron loss in the substantia nigra pars compacta, driven by mitochondrial Complex I dysfunction, oxidative stress, alpha-synuclein aggregation, and neuroinflammation. Cerebrolysin provides BDNF and GDNF-like neurotrophic support for surviving dopaminergic neurons and promotes neuroplasticity in compensatory basal ganglia circuits. Semax upregulates BDNF and reduces dopaminergic neurotoxicity via ACTH-analog neuroprotection. BPC-157 restores dopaminergic signaling, reduces neuroinflammation, and has demonstrated neuroprotection in MPTP-induced Parkinsonism models. Humanin specifically inhibits mitochondrial apoptosis in dopaminergic neurons and reduces alpha-synuclein oligomerization toxicity. NAD+ restores mitochondrial Complex I function, which is the primary metabolic defect in PD. Epithalon provides pineal-hypothalamic regulatory support and has demonstrated neuroprotective effects in aging neuronal circuits.
Clinical Research
No clinical references were provided for this stack yet.
More General Wellness Stacks
Altitude & Mountaineering Performance Protocol
A protocol for mountaineers, altitude athletes, and competitive cyclists targeting improved hypoxic adaptation, pulmonary vasodilation to prevent HAPE, enhanced oxygen utilization efficiency, and accelerated recovery from altitude-induced tissue stress.
COPD & Pulmonary Rehabilitation Protocol
An adjunctive protocol for individuals with COPD and other chronic lung diseases targeting the airway inflammation, pulmonary fibrosis, mucociliary dysfunction, and systemic muscle wasting that drive progressive respiratory decline.
Chronic Kidney Disease (CKD) Support Protocol
A nephroprotective protocol for patients with CKD stages 2–4, addressing progressive renal inflammation, anemia, muscle wasting (sarcopenia), peripheral neuropathy, and immune suppression through carefully selected peptides with renal safety profiles.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Parkinson's Disease Support Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.